Entrectinib in locally advanced or metastatic ROS1 fusion-positive non-small cell lung cancer (NSCLC): Integrated analysis of ALKA-372-001, STARTRK-1 and STARTRK-2
Titel:
Entrectinib in locally advanced or metastatic ROS1 fusion-positive non-small cell lung cancer (NSCLC): Integrated analysis of ALKA-372-001, STARTRK-1 and STARTRK-2
Auteur:
Barlesi, F. Drilon, A. De Braud, F. Cho, B.C. Ahn, M.J. Siena, S. Krebs, M.G. Lin, C.C. John, T. Tan, D.S.W. Seto, T. Dziadziuszko, R. Arkenau, H.-T. Rolfo, C. Wolf, J. Ye, C. Riehl, T. Eng, S. Doebele, R.C.